Cargando…
PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma–paraganglioma origin
Neuroendocrine tumors (NETs) are often diagnosed from the metastases of an unknown primary tumor. Specific immunohistochemical (IHC) markers indicating the location of a primary tumor are needed. The proprotein convertase subtilisin/kexin type 2 (PCSK2) is found in normal neural and neuroendocrine c...
Autores principales: | Remes, Satu Maria, Leijon, Helena, Vesterinen, Tiina, Louhimo, Johanna, Pulkkinen, Ville, Ezer, Sini, Kere, Juha, Haglund, Caj, Arola, Johanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702075/ https://www.ncbi.nlm.nih.gov/pubmed/32794589 http://dx.doi.org/10.1111/apm.13071 |
Ejemplares similares
-
Somatostatin receptor expression in parathyroid neoplasms
por: Storvall, Sara, et al.
Publicado: (2019) -
Neuropeptide S receptor 1 (NPSR1) activates cancer-related pathways and is widely expressed in neuroendocrine tumors
por: Pulkkinen, V., et al.
Publicado: (2014) -
Erratum to: “Neuropeptide S receptor 1 (NPSR1) activates cancer-related pathways and is widely expressed in neuroendocrine tumors
por: Pulkkinen, V., et al.
Publicado: (2014) -
Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning
por: Vesterinen, Tiina, et al.
Publicado: (2021) -
PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread
por: Vesterinen, Tiina, et al.
Publicado: (2019)